TF-S14 is a reverse agonist of RORgammat. TF-S14 reduces Th17 cell-associated cytokine production, including IL-17A, IL-21, and IL-22 by binding to and inhibiting RORgammat activity. TF-S14 can be used in the study of autoimmune diseases and rejection in allotransplantation[1].
Molekulargewicht:
397.53
CAS Nummer:
[2425563-60-4]
Formel:
C22H27N3O2S
Target-Kategorie:
ROR
Anwendungsbeschreibung:
MCE Product type: Reference compound1
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
